Skip to main content

Share story

Science Products

FDA clears Moderna's mRNA flu vaccine for adults 50 and older

Medical illustration of a single strand of messenger RNA in pink Image: Primary
The Food and Drug Administration has approved Moderna's mFlusiva, an mRNA vaccine for seasonal influenza, for adults ages 50 and older. Moderna filed for approval in February after the FDA had previously accepted the design of its final trial. The agency's vaccine advisory committee later voted unanimously to recommend approval. The vaccine is licensed and could be used without separate CDC recommendations, according to the report. But the CDC's guidance process remains uncertain amid litigation involving its advisory committee, and the absence of recommendations could affect insurance coverage and access.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Live Science and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Science
AI Science

Samsung reports faster chip simulations using AI and Nvidia GPUs

Samsung achieved a roughly 1,600x speedup in one chip engineering simulation by combining AI-predicted material properties, coarser computational grids and Nvidia GPU acceleration, Nvidia said.

AI Security
AI Security

AIM Intelligence integrates Starfort with Nvidia's agent security runtime

AIM Intelligence is integrating its Starfort agent control platform with Nvidia OpenShell to combine detection of malicious instructions and data leakage with runtime access controls, Nvidia announced. The integration targets employee productivity and enterprise workflows.